TAMMY CHU: Open Payments
NPI 1407337876 · ARCADIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,663 in 63 payments from 17 companies in 2025. Trend: 2023 $2,819 · 2024 $3,939 · 2025 $1,663
Food & beverage: $1,663
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 9 | $396 |
| Incyte Corporation | 9 | $246 |
| ABBVIE INC. | 11 | $241 |
| Regeneron Healthcare Solutions, Inc. | 4 | $151 |
| Lilly USA, LLC | 4 | $99 |
| Janssen Biotech, Inc. | 5 | $99 |
| LEO Pharma Inc. | 4 | $87 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $71 |
| PFIZER INC. | 3 | $53 |
| Galderma Laboratories, L.P. | 2 | $44 |
Products named: DUPIXENT, OPZELURA, RINVOQ, TALTZ, TREMFYA, ADBRY, SKYRIZI, ILUMYA.
Industry payments across CA — which companies pay providers there.
